4th Quarter - Report

AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS for AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS

Firm
Client
Income
—
Expenses
$202,071
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

Family planning (general); Maternal health (general).

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: State, Dept of (DOS); Indian Health Service; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Agency for Healthcare Research & Quality (AHRQ); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; White House Office; Homeland Security, Dept of (DHS); SENATE; Justice, Dept of (DOJ); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB)

Veterans VET

Assisted Reproductive Technology (general); Gender based health services (general); Provider scope of practice (general); Military Sexual Trauma (general); Abortion (general); H.R.1681/S. 700 Women Veterans and Families Health Services Act.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Agency for International Development (USAID); Indian Health Service; Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA)

Bills named: H.R. 1681 (115th), S. 700 (115th)

Environment/Superfund ENV

Implementation of P.L. 114-182, Frank R. Lautenberg Chemical Safety for the 21st Century Act

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); Executive Office of the President (EOP); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Justice, Dept of (DOJ); State, Dept of (DOS); White House Office; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Indian Health Service; Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA); Defense, Dept of (DOD); Health Resources & Services Administration (HRSA); Substance Abuse & Mental Health Services Administration (SAMHSA); Agriculture, Dept of (USDA)

Medicare/Medicaid MMM

Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Medicare reimbursement (general); Health Care Reform (general).

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Justice, Dept of (DOJ); Food & Drug Administration (FDA); White House Office; Agency for Healthcare Research & Quality (AHRQ); Agriculture, Dept of (USDA); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Agency for International Development (USAID); Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); SENATE; Indian Health Service; Health Resources & Services Administration (HRSA); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); Environmental Protection Agency (EPA); Office of Management & Budget (OMB)

Defense DEF

Implementation of P.L. 115-232, National Defense Authorization Act for Fiscal Year 2019; Congressionally Directed Medical Research Programs (CDMRP); Ovarian cancer (general); Gynecologic cancer (general); Contraception Access (general); Emergency Contraception (general); Military Sexual Trauma (general); Military Womens Health (general); Maternity Care (general); Postpartum care (general); Assisted Reproductive Technology (general); H.R. 2180/S. 957, Access to Contraception for Women Servicemembers and Dependents Act; S. 700 Women Veterans and Families Health Services Act.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Justice, Dept of (DOJ); Agriculture, Dept of (USDA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Homeland Security, Dept of (DHS); White House Office; Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Indian Health Service; Defense, Dept of (DOD)

Bills named: S. 957 (115th), H.R. 2180 (115th), S. 700 (115th)

Health Issues HCR

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); National Health Service Corps (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977/S. 3776, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; S. 3568, Rural MOMS Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 4993/S.3253, Vaccine Access Improvement Act of 2018; P.L. 115-271, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 756, First Step Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545, Violence Against Women Reauthorization Act.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Veterans Affairs, Dept of (VA); Homeland Security, Dept of (DHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Indian Health Service; Office of Management & Budget (OMB); SENATE; Justice, Dept of (DOJ); Executive Office of the President (EOP); Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); White House Office

Bills named: S. 3568 (115th), H.R. 1876 (115th), H.R. 4993 (115th), H.J.Res. 140 (115th), H.R. 6085 (115th), S. 2852 (115th), S. 756 (115th), H.R. 6545 (115th), H.R. 6805 (115th), S. 3253 (115th), S. 781 (115th), S. 3029 (115th), H.R. 5977 (115th), S. 3494 (115th), S. 1653 (115th), H.R. 6378 (115th), S. 3392 (115th), S.J.Res. 63 (115th), H.R. 5761 (115th), S. 2960 (115th), S. 783 (115th), H.R. 3602 (115th), H.R. 1318 (115th), S. 2637 (115th), S. 3776 (115th), H.R. 5457 (115th), S. 3363 (115th)

Budget/Appropriations BUD

Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); American Indian/Alaska Native womens health (general) (IHS); International Family Planning; Health Disparities (HHS); Safe Motherhood (CDC); Maternal Morbidity and Mortality (CDC, HRSA); Alliance for Innovation on Maternal Health (HRSA); Vital Statistics (CDC); Maternal Therapeutics Research and Regulation (HHS, NIH, FDA); Reproductive Health (general); Medicaid and Medicare (CMS); Division of Reproductive Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); National Center on Birth Defects and Developmental Disabilities (CDC); Fetal Tissue Research (NIH); National Health Service Corps (HRSA); Substance Use Disorder Treatment (SAMHSA); implementation of P.L. 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Agriculture, Dept of (USDA); U.S. Agency for International Development (USAID); Indian Health Service; Justice, Dept of (DOJ); Environmental Protection Agency (EPA); White House Office; Agency for Healthcare Research & Quality (AHRQ); Veterans Affairs, Dept of (VA); SENATE; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); Office of Natl Drug Control Policy (NDCP); Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Office of Management & Budget (OMB)

Immigration IMM

Immigration and womens health (general); Health care work force (general); Public Charge; Abortion (general); Pregnant women in immigration detention; S. 3225, Stop Shackling and Detaining Pregnant Women Act.

LobbyistCovered position, as disclosed
LUCIA DIVENERE —
REBECCA LEA NATHANSON —
MALLORY SCHWARZ —
RACHEL TETLOW —

Contacted: Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); SENATE; Defense, Dept of (DOD); Agriculture, Dept of (USDA); U.S. Agency for International Development (USAID); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Office of Management & Budget (OMB); State, Dept of (DOS); Health Resources & Services Administration (HRSA); Indian Health Service; Natl Institutes of Health (NIH); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ)

Bills named: S. 3225 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.